Device Trial Radar · NCT04331587
Thin and Ultrathin Bronchoscopy With Transbronchial Needle Aspiration and Radial Probe Endobronchial Ultrasound for Peripheral Pulmonary Lesions
Last checked: Nov 19, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
80
Actual
Start
Apr 20, 2020
Primary completion
Aug 22, 2024
Study completion Aug 22, 2024
Sponsor
- Lead sponsor
- Washington University School of MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Olympus
- First posted
- Apr 2, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To collect data on diagnostic yield of thin and ultrathin bronchoscopes with radial probe endobronchial ultrasound (radial EBUS) and transbronchial needle aspiration (TBNA) during routine standard of care bronchoscopy for peripheral pulmonary lesions.
Conditions
- Peripheral Pulmonary Nodules
Interventions
BF-P190 4 mm thin bronchoscopeDevice
* EVIS EXERA III Bronchofiberviedoscopes * Olympus
BF-MP190F 3 mm ultrathin bronchoscopeDevice
* EVIS EXERA III Bronchofiberviedoscopes * Olympus
Radial ultrasound probe (UM S20-17S)Device
-Olympus
PeriView FLEX 21G Single Use Aspiration NeedleDevice
* NA-403D-2021 * Gyrus ACMI, Inc.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall diagnostic yield (concentric and eccentric lesions) for peripheral pulmonary nodulesTime frame: Receipt of cytology/histopathology results (approximately 7 days)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Washington University School of Medicine
St Louis, Missouri
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.